Sonnie Kim, Pharm.D.
Chief Scientific Officer
Dr. Sonnie Kim offers 20 years of leadership experience driving medical affairs and scientific programs. At Braeburn, Sonnie oversees clinical trial design and execution and leads all medical affairs activities. Prior to joining Braeburn, she was with Otsuka America Pharmaceutical, Inc., as the Director of Medical Affairs/Hospital Medicine. She was integral in the pre and post-launch medical affairs activities and programs for SAMSCA (tolvaptan). Previously with WebMD, she developed and deployed analytical tools to shape the Medscape Education strategy. Sonnie’s previous experience also includes roles as VP and board member of Columbia Medcom Group, and its subsidiary, Medicalliance.